Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
1.060
0.00 (0.00%)
Apr 29, 2025, 1:15 PM EDT - Market open
Predictive Oncology Employees
As of December 31, 2024, Predictive Oncology had 24 total employees, including 23 full-time and 1 part-time employees. The number of employees decreased by 11 or -31.43% compared to the previous year.
Employees
24
Change (1Y)
-11
Growth (1Y)
-31.43%
Revenue / Employee
$67,659
Profits / Employee
-$527,683
Market Cap
9.47M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
POAI News
- 4 weeks ago - Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - GlobeNewsWire
- 5 weeks ago - Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewsWire
- 2 months ago - Predictive Oncology Closes Registered Direct Offering - GlobeNewsWire
- 2 months ago - Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing - GlobeNewsWire
- 2 months ago - Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform - Business Wire
- 3 months ago - AIRNA Appoints Matthew Hawryluk as Chief Business Officer - Business Wire
- 3 months ago - Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay - GlobeNewsWire